Clinical Trial


Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy


Brief description

The purpose of the study is to test whether vaccinations with CYT003-QbG10 can improve allergy symptoms in patients with house dust mite allergy. The active treatment will be compared against placebo.

Keywords

  •   Allergies
  •   Rhinoconjunctivitis

Sponsored By

Cytos Biotechnology AG

Unique Study ID

NCT00800332

Investigators and Research Sites Near You - Found( 0 )